6 Biotechnology Stocks to Buy Now

The grades of six biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

This week, La Jolla Pharmaceutical Company (LJPC) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). In Portfolio Grader’s specific subcategories of Earnings Momentum and Earnings Revisions, LJPC also gets A’s. For more information, get Portfolio Grader’s complete analysis of LJPC stock.

Idenix Pharmaceuticals, Inc. (IDIX) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Idenix Pharmaceuticals is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. For more information, get Portfolio Grader’s complete analysis of IDIX stock.

This week, Incyte Corporation’s (INCY) ratings are up from a C last week to a B. Incyte is using its expertise in genomics and medicinal chemistry, as well as molecular, cellular, and in vivo biology to discover and develop novel therapeutics. For more information, get Portfolio Grader’s complete analysis of INCY stock.

Progenics Pharmaceuticals, Inc.’s (PGNX) ratings are looking better this week, moving up to a B from last week’s C. Progenics Pharmaceuticals develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. For more information, get Portfolio Grader’s complete analysis of PGNX stock.

This week, Celladon Corporation (CLDN) pushes up from a B to an A rating. For more information, get Portfolio Grader’s complete analysis of CLDN stock.

Tobira Therapeutics, Inc. (TBRA) shows solid improvement this week. The company’s rating rises from a C to a B. For more information, get Portfolio Grader’s complete analysis of TBRA stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/09/6-biotechnology-stocks-to-buy-now-ljpc-idix-incy/.

©2021 InvestorPlace Media, LLC